268
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn’s disease; the Sensitivity to Change (STOC) study

ORCID Icon, ORCID Icon, , , , , , ORCID Icon & show all
Pages 439-445 | Received 19 Nov 2021, Accepted 08 Dec 2021, Published online: 30 Dec 2021

References

  • Frøslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133(2):412–422.
  • Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med. 2010;362(15):1383–1395.
  • Rutgeerts P, Van Assche G, Sandborn WJ, et al. Adalimumab induces and maintains mucosal healing in patients with Crohn’s disease: data from the EXTEND trial. Gastroenterology. 2012;142(5):1102–1111 e1102.
  • Löwenberg M, Vermeire S, Mostafavi N, et al. Vedolizumab induces endoscopic and histologic remission in patients with crohn’s disease. Gastroenterology. 2019;157(4):997–e1006.
  • Makkar R, Bo S. Colonoscopic perforation in inflammatory bowel disease. Gastroenterol Hepatol. 2013;9(9):573–583.
  • Ryhlander J, Ringstrom G, Simrén M, et al. Undergoing repeated colonoscopies - experiences from patients with inflammatory bowel disease. Scand J Gastroenterol. 2019;54(12):1467–1472.
  • Cortegoso Valdivia P, Elosua A, Houdeville C, et al. Clinical feasibility of panintestinal (or panenteric) capsule endoscopy: a systematic review. Eur J Gastroenterol Hepatol. 2021;33(7):949–955.
  • D’Haens G, Lowenberg M, Samaan MA, et al. Safety and feasibility of using the Second-Generation pillcam Colon capsule to assess active colonic crohn's disease. Clin Gastroenterol Hepatol. 2015;13(8):1480–1486 e1483.
  • Boal Carvalho P, Rosa B, Dias de Castro F, et al. PillCam Colon 2 in Crohn’s disease: a new concept of pan-enteric mucosal healing assessment. World J Gastroenterol. 2015;21(23):7233–7241.
  • Yamada K, Nakamura M, Yamamura T, et al. Diagnostic yield of Colon capsule endoscopy for Crohn’s disease lesions in the whole gastrointestinal tract. BMC Gastroenterol. 2021;21(1):75.
  • Oliva S, Aloi M, Viola F, et al. A treat to target strategy using panenteric capsule endoscopy in pediatric patients with Crohn’s disease. Clin Gastroenterol Hepatol. 2019;17(10):2060–2067.e2061.
  • Leighton JA, Rex DK. A grading scale to evaluate Colon cleansing for the PillCam Colon capsule: a reliability study. Endoscopy. 2011;43(2):123–127.
  • Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–512.
  • Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30(7):983–989.
  • Danese S, Sandborn WJ, Colombel J-F, et al. Endoscopic, radiologic, and histologic healing with vedolizumab in patients with active crohn's disease. Gastroenterology. 2019;157(4):1007–1018.e1007.
  • Ferrante M, Colombel JF, Sandborn WJ, et al. Validation of endoscopic activity scores in patients with Crohn’s disease based on a post hoc analysis of data from SONIC. Gastroenterology. 2013;145(5):978–986.e975.
  • Leenhardt R, Buisson A, Bourreille A, et al. Nomenclature and semantic descriptions of ulcerative and inflammatory lesions seen in crohn's disease in small bowel capsule endoscopy: an international delphi consensus statement. United European Gastroenterol J. 2020;8(1):99–107.
  • Norman GR, Wyrwich KW, Patrick DL. The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res. 2007;16(5):815–822.
  • Rutgeerts P, Diamond RH, Bala M, et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease. Gastrointest Endosc. 2006;63(3):433–442. quiz 464.
  • Rivière P, D’Haens G, Peyrin-Biroulet L, et al. Location but not severity of endoscopic lesions influences endoscopic remission rates in crohn's disease: a post hoc analysis of TAILORIX. Am J Gastroenterol. 2021;116(1):134–141.
  • Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn’s disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):544–558.
  • Tontini GE, Rizzello F, Cavallaro F, et al. Usefulness of panoramic 344°-viewing in crohn’s disease capsule endoscopy: a proof of concept pilot study with the novel PillCam™ Crohn’s system. BMC Gastroenterol. 2020;20(1):97.
  • Gralnek IM, Defranchis R, Seidman E, et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2007;27(2):146–154.
  • M, Camí M, Serracarbasa A, D’Haens G, et al. Characterization of mucosal lesions in Crohn’s disease scored with capsule endoscopy: a systematic review. Front Med. 2020;7:600095.
  • Niv Y, Gal E, Gabovitz V, et al. Capsule endoscopy Crohn’s disease activity index (CECDAIic or niv score) for the small bowel and Colon. J Clin Gastroenterol. 2018;52(1):45–49.
  • Eliakim R, Yablecovitch D, Lahat A, et al. A novel PillCam Crohn’s capsule score (eliakim score) for quantification of mucosal inflammation in Crohn’s disease. United European Gastroenterol J. 2020;8(5):544–551.
  • Tai FWD, Ellul P, Elosua A, et al. Panenteric capsule endoscopy identifies proximal small bowel disease guiding upstaging and treatment intensification in Crohn’s disease: a European multicentre observational cohort study. United European Gastroenterol J. 2020;2020:2050640620948664.
  • Oliva S, Cucchiara S, Civitelli F, et al. Colon capsule endoscopy compared with other modalities in the evaluation of pediatric Crohn’s disease of the small bowel and colon. Gastrointest Endosc. 2016;83(5):975–983.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.